Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk: a European Perspective
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In the European Union (EU), allergens used for diagnostic tests (TA s) are defined as medicinal products and have to be registered by national authorities. The current situation is not homogeneous. Existing authorizations need to be kept in the market in some EU states, while others need complete new authorizations requiring clinical trials, quality assurance methods, stability studies, and periodic safety update reports. Allergen manufacturers argue that offering a comprehensive panel of TA s may be economically disastrous. Expenses for initiation and maintenance of TA authorizations far exceed their related revenues and manufacturers may be forced to significantly limit their allergen portfolios. The availability of a wide range of high‐quality TA s is very important for in vivo diagnoses of IgE‐mediated allergies. Increased regulatory demands induce costs that need to be covered by public health organizations or reimbursed by health insurance companies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo diagnosis of allergic diseases-allergen provocation tests
Agache, I., Bilò, M., Braunstahl, G.-J., Delgado, L., Demoly, P., Eigenmann, P., Gevaert, P., Gomes, E., Hellings, P., Horak, F., et al. (2015) · Allergy · doi:10.1111/all.12586 · Cited by 104
Self-citation
Cited by
EAACI Molecular Allergology User's Guide
Matricardi, P. M., Kleine‐Tebbe, J., Hoffmann, H. J., Valenta, R., Hilger, C., Hofmaier, S., Aalberse, R. C., Agache, I., Asero, R., Ballmer‐Weber, B., et al. (2016) · Pediatric Allergy and Immunology · doi:10.1111/pai.12563 · Cited by 932
Self-citationAnsotegui, I. J., Melioli, G., Canonica, G. W., Caraballo, L., Villa, E., Ebisawa, M., Passalacqua, G., Savi, E., Ebo, D., Gómez, R. M., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2019.100080 · Cited by 489
Self-citationEAACI Molecular Allergology User's Guide 2.0
Dramburg, S., Hilger, C., Santos, A. F., de las Vecillas, L., Aalberse, R. C., Acevedo, N., Aglas, L., Altmann, F., Arruda, K. L., Asero, R., et al. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13854 · Cited by 298
Self-citationImmunoCAP Assays: Pros and Cons in Allergology
van Hage, M., Hamsten, C., & Valenta, R. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.008 · Cited by 175
Conjunctival allergen provocation test : guidelines for daily practice
Fauquert, J.-L., Jedrzejczak-Czechowicz, M., Rondon, C., Calder, V., Silva, D., Kvenshagen, B. K., Callebaut, I., Allegri, P., Santos, N., Doan, S., et al. (2017) · Allergy · doi:10.1111/all.12986 · Cited by 126
Pros and Cons of Clinical Basophil Testing (BAT)
Hoffmann, H. J., Knol, E. F., Ferrer, M., Mayorga, L., Sabato, V., Santos, A. F., Eberlein, B., Nopp, A., & MacGlashan, D. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0633-6 · Cited by 50
Self-citationRiabova, K., Karsonova, A. V., van Hage, M., Käck, U., Konradsen, J. R., Grönlund, H., Fomina, D., Beltyukov, E., Glazkova, P. A., Semenov, D. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136984 · Cited by 21
Usefulness of component resolved analysis of cat allergy in routine clinical practice
Eder, K., Becker, S., San Nicoló, M., Berghaus, A., & Gröger, M. (2016) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-016-0163-8 · Cited by 21
The Clinical Impact of Bet v 6 in Birch Pollen-Sensitized Patients
Gellrich, D., Eder, K., San Nicoló, M., Berghaus, A., & Gröger, M. (2017) · International Archives of Allergy and Immunology · doi:10.1159/000470843 · Cited by 2
Metadata
- Authors
- Klimek, L., Hoffmann, H. J., Renz, H., Demoly, P., Werfel, T., Matricardi, P. M., Muraro, A., Schmid‐Grendelmeier, P., Cardona, V., & Papadopoulos, N. G.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2015-08-19
- Volume
- 70
- Issue
- 10
- Pages
- 1329-1331
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1678652856
- Cited by
- 46
- References
- 1
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.